TABLE 1.
NAP | Sequence | Length (nt) | PS | 2′OMe | 5-MeC |
---|---|---|---|---|---|
REP 2006 | dN40 | 40 | + | ||
REP 2031 | dC40 | 40 | + | ||
REP 2181 | (dAdC)50 | 100 | + | ||
REP 2180 | (dAdC)40 | 80 | + | ||
REP 2149 | (dAdC)30 | 60 | + | ||
REP 2055 | (dAdC)20 | 40 | + | ||
REP 2150 | (dAdC)15 | 30 | + | ||
REP 2151 | (dAdC)10 | 20 | + | ||
REP 2152 | (dAdC)5 | 10 | + | ||
REP 2107 | N40 | 40 | + | + | |
REP 2138 | C40 | 40 | + | ||
REP 2139 | (AC)20 | 40 | + | + | + |
REP 2165 | (AC)20 | 40 | + | +b | + |
REP 2147 | (AC)20 | 40 | + | + | |
REP 2172 | (AC)20 | 40 | + |
Abbreviations: d, DNA; N, degenerate sequence; PS, phosphorothioation of phosphodiester linkage (increases amphipathicity); 2′OMe, O-linked methylation at the 2′ position in ribose (increased stability and reduced Toll-like receptor [TLR] reactivity); 5-MeC, methylation at the 5′ position in cytidine base (reduced TLR reactivity).
Positions 11, 21, and 31 have 2′OH ribose.